# ARNA Pharma Pty., Ltd. – FDA Inspection, Oct 17, 2025

Source: https://www.keypedia.com/records/fda_inspections/arna-pharma-pty-ltd/9b8d027e-c374-4b0f-ab14-c27618e3b54f
Source feed: FDA_Inspections

> FDA inspection 1288492 of ARNA Pharma Pty., Ltd., October 17, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1288492
- Company Name: ARNA Pharma Pty., Ltd.
- Inspection Date: 2025-10-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 3

## Related Documents

- [FDA Inspection 1089805 - 2019-05-17](https://www.keypedia.com/records/fda_inspections/arna-pharma-pty-ltd/f801236b-b289-486d-a01b-07ea4fe53d46)
- FDA Inspection 1069444 - 2018-08-03
- FDA Inspection 804043 - 2012-09-21
- FDA Inspection 623897 - 2009-10-16

## Related Officers

- [Paranthaman Senthamarai Kannan](https://www.keypedia.com/people/paranthaman-senthamarai-kannan/12221263-b29b-4696-9e6e-84e659ae43cd)

Company: https://www.keypedia.com/companies/arna-pharma-pty-ltd/e06145c8-ecf7-4bc1-9e0d-5aab8615b08f

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
